MedTrace Logo

COVID-19 Sero-prevalence Health Care Workers Kinshasa

NCT04699058 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2022-12-02

No results posted yet for this study

Summary

This is a cohort study, in which the investigators will follow-up 650 health care workers (HCW) and a selection of their households (of COVID positive and COVID negative HCW) at baseline and in three follow-up surveys, with 4 to 6 weeks of time interval. The investigators will select HCW from different wards and different health care structures in 5 communes of Kinshasa. Additionally, in the first survey among HCW, the investigators will test with different diagnostic platform to evaluate the performance of serological tests in the African setting and the effect of malaria infection on the performance of tests.

An amendment is added to the protocol, stating an additional 2 surveys in april/June 2021 and October/November 2021 to evaluate impact of second wave and of vaccination campaign.

Conditions

  • SARS-CoV Infection
  • Seroprevalence

Interventions

DIAGNOSTIC_TEST

COVID-antibody test

Questionnaire and COVID-antibody test for all participants

Sponsors & Collaborators

  • Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo

    collaborator OTHER

  • Institute of Tropical Medicine, Belgium

    lead OTHER

Principal Investigators

  • Veerle Vanlerberghe, PhD · ITG

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-17
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Democratic Republic of the Congo

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04699058 on ClinicalTrials.gov